60 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
” means (a) all trademarks, trade names, corporate names, company names, business names, fictitious business names, service marks, elements of package
8-K/A
EX-10.2
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
not work or is no longer working, in each case of (i) and (ii), as approved by the FDA regardless of any description on the package of the Product
8-K
nwtga
26 Dec 23
Other Events
8:49pm
8-K/A
EX-99.1
x7rwxvbfai2
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
424B5
mpogx8pv7dr45a02umn
12 Sep 23
Prospectus supplement for primary offering
6:04am
424B3
9bf3muxcgknl4
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
pg6v1
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
ha2whdsh4
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
cay5mst0iu
16 Jun 23
Business combination disclosure
5:11pm
8-K
EX-1.1
agws0f7lr2e39l9y
18 May 23
Other Events
5:02pm
424B5
2rz7uto9uujh22
17 May 23
Prospectus supplement for primary offering
4:02pm
424B5
uvz2aj5vbt wume
16 May 23
Prospectus supplement for primary offering
6:07am